Literature DB >> 28800462

Imaging, biodistribution and in vitro study of smart 99mTc-PAMAM G4 dendrimer as novel nano-complex.

Asghar Narmani1, Kamal Yavari2, Javad Mohammadnejad1.   

Abstract

Overexpression of folic acid receptor in various human tumors cells makes it as good candidate for targeting delivery of chemotherapeutic and radiopharmaceutical agents. In this research, FA used for functionalization of PEG modified PAMAM G4 dendrimer as a smart delivery of 5-FU and 99mTc for the breast carcinoma in order to chemotherapeutic and imaging goals. One aim of this research was assess the FA-mediated cell viability assay of PEG-PAMAM G4-FA-5FU-99mTc and in vitro uptake of PEG-PAMAM G4-FA-99mTc as the novel nano-complex determined on C2Cl2 (normal cell) and MCF-7 (breast cancer cell) cell lines. Other main goals were studied. Morover, an investigation in to in vivo imaging and biodistribution was carried out via a novel radio tracer by which tumor accumulation and site were obviously detected. The targeted tumor images taken by tail intravenous injection demonstrated that nano-complex can be smartly used in imaging study of the clinical practices. Also, the biodistribution of this nano-complex was investigated and the organ predestination of 99mTc labeled nano-complex (%ID/g) was ascertained.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  (99m)Tc; Biodistribution; Breast cancer targeting; Cellular uptake and viability; Folic acid and 5-FU; Imaging

Mesh:

Substances:

Year:  2017        PMID: 28800462     DOI: 10.1016/j.colsurfb.2017.07.089

Source DB:  PubMed          Journal:  Colloids Surf B Biointerfaces        ISSN: 0927-7765            Impact factor:   5.268


  5 in total

1.  Margetuximab conjugated-PEG-PAMAM G4 nano-complex: a smart nano-device for suppression of breast cancer.

Authors:  Yasaman Khakinahad; Saeedeh Sohrabi; Shokufeh Razi; Asghar Narmani; Sepideh Khaleghi; Mahboubeh Asadiyun; Hanieh Jafari; Javad Mohammadnejad
Journal:  Biomed Eng Lett       Date:  2022-04-05

Review 2.  Preclinical Advances in Theranostics for the Different Molecular Subtypes of Breast Cancer.

Authors:  Hanyi Fang; Alessandra Cavaliere; Ziqi Li; Yiyun Huang; Bernadette Marquez-Nostra
Journal:  Front Pharmacol       Date:  2021-04-27       Impact factor: 5.810

3.  Meta-Analysis of Nanoparticle Delivery to Tumors Using a Physiologically Based Pharmacokinetic Modeling and Simulation Approach.

Authors:  Yi-Hsien Cheng; Chunla He; Jim E Riviere; Nancy A Monteiro-Riviere; Zhoumeng Lin
Journal:  ACS Nano       Date:  2020-03-04       Impact factor: 15.881

4.  Synthesis and Evaluation of 177Lu-DOTA-DN(PTX)-BN for Selective and Concomitant Radio and Drug-Therapeutic Effect on Breast Cancer Cells.

Authors:  Brenda Gibbens-Bandala; Enrique Morales-Avila; Guillermina Ferro-Flores; Clara Santos-Cuevas; Myrna Luna-Gutiérrez; Gerardo Ramírez-Nava; Blanca Ocampo-García
Journal:  Polymers (Basel)       Date:  2019-09-27       Impact factor: 4.329

Review 5.  Single- versus Dual-Targeted Nanoparticles with Folic Acid and Biotin for Anticancer Drug Delivery.

Authors:  Magdalena Jurczyk; Katarzyna Jelonek; Monika Musiał-Kulik; Artur Beberok; Dorota Wrześniok; Janusz Kasperczyk
Journal:  Pharmaceutics       Date:  2021-03-03       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.